Bruno Gagnon
Corporate Officer/Principal bei OPTHEA LIMITED
Profil
Bruno Gagnon is a professional with experience in various firms.
He is currently working as Senior Vice President-Global Clinical Operations at Opthea Ltd.
He has previously worked as Vice President-Clinical Operations at BioMarin Pharmaceutical, Inc. and as Senior Vice President-Development Operations at Eidos Therapeutics, Inc. Mr. Gagnon has completed his graduate degree from the University of Montréal and his undergraduate degree from Université Laval.
Aktive Positionen von Bruno Gagnon
| Unternehmen | Position | Beginn |
|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 01.07.2022 |
Ehemalige bekannte Positionen von Bruno Gagnon
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Operating Officer | - |
| EIDOS THERAPEUTICS, INC. | Chief Operating Officer | - |
Ausbildung von Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
